A lipidomics approach reveals novel phospholipid changes in palmitate-treated C2C12 myotubes

Lipids. 2024 Mar;59(2):55-63. doi: 10.1002/lipd.12387. Epub 2024 Feb 1.

Abstract

Type 2 diabetes mellitus (T2DM) is a highly prevalent metabolic disorder. Insulin resistance and oxidative stress are associated with T2DM development. The hypothesis that patients with T2DM show excess accumulation of lipids, such as ceramides (Cers) and diacylglycerols (DAGs), in their skeletal muscles has been widely supported; however, detailed lipidomic data at the molecular species level are limited. Therefore, in this study, we aimed to investigate the in vitro dynamics of total lipids, including phospholipids (PLs), sphingolipids, and neutral lipids, in palmitic acid-induced insulin-resistant C2C12 skeletal muscle cells. Our data demonstrated that the profiles of not only Cers and DAGs but also those of PLs showed considerably differences after palmitate treatment. We found that PL synthesis reduced and PL degradation increased after palmitate treatment. These findings may aid in the development of treatments to ameliorate muscle dysfunction caused by lipid accumulation in muscles.

Keywords: C2C12 myotubes; molecular species; neutral lipids; palmitate; phospholipids.

MeSH terms

  • Ceramides / metabolism
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / metabolism
  • Humans
  • Insulin Resistance* / physiology
  • Lipidomics
  • Muscle Fibers, Skeletal / metabolism
  • Muscle, Skeletal / metabolism
  • Palmitates / pharmacology
  • Phospholipids / metabolism
  • Signal Transduction

Substances

  • Palmitates
  • Phospholipids
  • Ceramides